Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (277)
- COVID-19 (163)
- Safety monitoring and information (101)
- Legislation (95)
- Compliance and enforcement (70)
- Manufacturing (55)
- Vaping hub (54)
- Labelling and packaging (37)
- Import and export (28)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1263 result(s) found, displaying 951 to 975
-
Media releasesThe TGA has issued twelve infringement notices to a Victorian-based pharmacist for alleged unlawful advertising of therapeutic goods
-
Media releasesThe TGA has issued five infringement notices to Sydney-based company Chemforce Pty Ltd
-
Media releasesTGA taking action on sunscreens tested by AMA Laboratories
-
Hydrogen Technologies fined $50,400 for alleged advertising breaches including reference to COVID-19
Media releasesThe TGA has issued four infringement notices totalling $50,400 to Cairns based company Hydrogen Technologies Pty Ltd for alleged advertising breaches including reference to COVID-19 -
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Media releasesThe Federal Court of Australia has made orders restraining MMS Australia from advertising and supplying goods containing certain potentially dangerous substances until a further hearing next week
-
News articlesNew modelling demonstrates that supply of critical medicines for ventilating patients supports a return to elective surgery
-
Media releasesThe reforms will enable the safe and effective prescribing and use of opioids while maintaining access for patients who need them.
-
Media releasesThe TGA has initiated proceedings in the Federal Court of Australia in response to the alleged unlawful advertising of Miracle Mineral Supplement (MMS), dimethyl sulfoxide (DMSO) and other medicines by Southern Cross Directories Pty Ltd trading as MMS Australia
-
Media releasesThe TGA is reminding advertisers that therapeutic goods advertising must not undermine public health campaigns, as the cold and flu season begins in Australia and COVID-19 restrictions are eased
-
Media releasesThe TGA has issued four infringement notices totalling $50,400 to Brisbane based company Allpulse Technologies Pty Ltd
-
Media releasesThe TGA has issued a $12,600 infringement notice to Melbourne based company NutriPATH Pty Ltd for the alleged unlawful advertising of a COVID-19 Polymerase Chain Reaction (PCR) test collection kit.
-
Compliance undertakingsUndertaking given to the Secretary of the Australian Government Department of Health for the purposes of section 42YL of the Act
-
Media releasesThe TGA has issued fifteen infringement notices totalling $37,800 to a doctor in Perth
-
News articlesAds for health products are everywhere, but don't believe everything you read
-
Media releasesThe TGA has issued twelve infringement notices totalling $151,200 for the alleged unlawful advertising of Miracle Mineral Supplement and other medicines
-
Media releasesFrom 1 July 2020, medicine advertisements in specified media do not need pre-approval from the TGA
-
-
Media releasesThe TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits
-
Media releasesThe TGA has issued five infringement notices totalling $63,000 to a Queensland company for alleged breaches relating to COVID-19 test kits
-
Regulatory decision noticesInformation on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19
-
BlogHow to find information about the inactive ingredients in your medicines.
-
Media releasesTo improve access to important ingredient information, TGA publishes the names of excipients in medicines and biologicals on its website
-
News articlesIn response to the COVID-19 pandemic, the TGA is implementing Serious Shortage Medicine Substitution Notices
-
Media releasesThe TGA has issued two infringement notices to Peter Evans' company totalling $25,200 for alleged breaches of therapeutic goods legislation in relation to the promotion of a 'BioCharger' device